GILIO, LUANA
 Distribuzione geografica
Continente #
NA - Nord America 189
AS - Asia 131
EU - Europa 121
SA - Sud America 1
Totale 442
Nazione #
US - Stati Uniti d'America 182
HK - Hong Kong 80
DE - Germania 77
SG - Singapore 45
IT - Italia 33
BE - Belgio 6
CA - Canada 6
GB - Regno Unito 4
BD - Bangladesh 3
IL - Israele 3
BR - Brasile 1
LT - Lituania 1
MX - Messico 1
Totale 442
Città #
Hong Kong 80
Frankfurt am Main 76
West Jordan 66
Boardman 41
Singapore 28
Brussels 6
Buffalo 6
Rome 6
Bologna 4
Charlotte 4
Sant'Elpidio a Mare 4
Arosio 3
Naples 3
Ottawa 3
Toronto 3
Ashburn 2
London 2
Zona Industriale 2
Council Bluffs 1
Ettlingen 1
Kiryat Ono 1
Los Angeles 1
Mexico City 1
Milan 1
São Paulo 1
Totale 346
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 20
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 17
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 16
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 16
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 15
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 15
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 14
Osteopontin Is Associated with Multiple Sclerosis Relapses 13
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 13
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 13
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 13
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 13
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 12
Amyloid-β homeostasis bridges inflammation, synaptic plasticity deficits and cognitive dysfunction in multiple sclerosis 12
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 12
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 12
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 12
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 12
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 12
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 12
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 12
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 11
Obesity worsens central inflammation and disability in multiple sclerosis 11
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 11
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 11
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 10
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 10
Synaptic plasticity shapes brain connectivity: Implications for network topology 10
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 10
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 10
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 10
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 9
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 9
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 9
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 9
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 9
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 9
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 9
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 9
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis 8
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 8
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 7
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 6
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 5
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 5
Totale 501
Categoria #
all - tutte 5.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024219 0 0 0 0 0 0 52 0 0 137 15 15
2024/2025282 40 57 7 25 64 54 35 0 0 0 0 0
Totale 501